NCR3 and metastatic malignant neoplasm in the lymph nodes: In non-metastatic pancreatic cancer, the percentage of NKG2D and NKp30 positive NK cells were significantly decreased in patients with lymph node metastasis than patients without lymph node metastasis (both P < 0.05).